"サノフィ" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonSanofi signs €545M deal to explore Formation’s JAK/SYK inhibitor in new indication - Fierce Biotech
Sanofi signs €545M deal to explore Formation’s JAK/SYK inhibitor in new indication Fierce Biotech
Formation Bio Licenses Gusacitinib to Sanofi - Contract Pharma
Formation Bio Licenses Gusacitinib to Sanofi Contract Pharma
Sanofi licenses Formation Bio's JAK/SYK inhibitor for up to €545M - FirstWord Pharma
Sanofi licenses Formation Bio's JAK/SYK inhibitor for up to €545M FirstWord Pharma
Sanofi, Regeneron Get FDA Approval for Dupixent to Treat Rare Skin Disease - WSJ
Sanofi, Regeneron Get FDA Approval for Dupixent to Treat Rare Skin Disease WSJ
BIO2025: Sanofi R&D, FDA's Martin Makary, Paying For New Therapies - Life Science Leader
BIO2025: Sanofi R&D, FDA's Martin Makary, Paying For New Therapies Life Science Leader
Sanofi/Regeneron’s Dupixent granted FDA approval for bullous pemphigoid - PMLiVE
Sanofi/Regeneron’s Dupixent granted FDA approval for bullous pemphigoid PMLiVE
Sanofi & Regeneron's Dupixent Gets FDA Nod for Bullous Pemphigoid - Yahoo Finance
Sanofi & Regeneron's Dupixent Gets FDA Nod for Bullous Pemphigoid Yahoo Finance
DoH – Abu Dhabi and Sanofi link for vaccine development - Pharmaceutical Technology
DoH – Abu Dhabi and Sanofi link for vaccine development Pharmaceutical Technology
Press Release: Sarclisa recommended for EU approval by the - GlobeNewswire
Press Release: Sarclisa recommended for EU approval by the GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanofi - SNY - P...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanofi - SNY PR Newswire
Sanofi teams up with Abu Dhabi to fast-track vaccine development - The Pharma Letter
Sanofi teams up with Abu Dhabi to fast-track vaccine development The Pharma Letter
Weil Advises Sanofi in its $9.5 Billion Acquisition of Blueprint Medicines - Weil
Weil Advises Sanofi in its $9.5 Billion Acquisition of Blueprint Medicines Weil
Digital Transformation and Artificial Intelligence - Sanofi
Sanofi (ENXTPA:SAN) Gains FDA Approval For Dupixent To Address Rare Skin Disease - simplywall.st
Sanofi (ENXTPA:SAN) Gains FDA Approval For Dupixent To Address Rare Skin Disease simplywall.st
Sanofi to buy US biopharma group Blueprint for up to $9.5 billion - Reuters
Sanofi to buy US biopharma group Blueprint for up to $9.5 billion Reuters
DoH Abu Dhabi and Sanofi partner to boost global vaccine development - World Pharmaceutical Front...
DoH Abu Dhabi and Sanofi partner to boost global vaccine development World Pharmaceutical Frontiers
Sanofi, Regeneron's Dupixent scores eighth FDA nod, this time for bullous pemphigoid - FirstWord ...
Sanofi, Regeneron's Dupixent scores eighth FDA nod, this time for bullous pemphigoid FirstWord Pharma
Ventyx posts phase 2 Parkinson's data ahead of potential talks with Sanofi - Fierce Biotech
Ventyx posts phase 2 Parkinson's data ahead of potential talks with Sanofi Fierce Biotech
Sanofi: Information concerning the total number of voting rights and shares - May 2025 - GlobeNew...
Sanofi: Information concerning the total number of voting rights and shares - May 2025 GlobeNewswire
Environmental Impact and Healthcare Systems’ Resilience - Sanofi
Environmental Impact and Healthcare Systems’ Resilience Sanofi
Regeneron, Sanofi say Dupixent label expanded in US (REGN) - Seeking Alpha
Regeneron, Sanofi say Dupixent label expanded in US (REGN) Seeking Alpha
Breakingviews - Sanofi finds M&A fix for its multiple itches - Reuters
Breakingviews - Sanofi finds M&A fix for its multiple itches Reuters
ASCO: Sanofi shows investigational Sarclisa SC, delivered by on-body device, measures up to its I...
ASCO: Sanofi shows investigational Sarclisa SC, delivered by on-body device, measures up to its IV formulation Fierce Pharma
Feeling RSV heat from Merck, Sanofi lays out early supply plans for Beyfortus - Fierce Pharma
Feeling RSV heat from Merck, Sanofi lays out early supply plans for Beyfortus Fierce Pharma
With Opella proceeds burning a hole in its pocket, Sanofi snaps up Blueprint for $9.1B - Fierce P...
With Opella proceeds burning a hole in its pocket, Sanofi snaps up Blueprint for $9.1B Fierce Pharma
Blueprint Medicines Stock Soars as Biotech Agrees to Over $9B Sanofi Takeover - Investopedia
Blueprint Medicines Stock Soars as Biotech Agrees to Over $9B Sanofi Takeover Investopedia
Sustainability: Building a Healthier World - Sanofi
GSK snags longtime Sanofi exec to lead vaccine and infectious disease R&D - Fierce Biotech
GSK snags longtime Sanofi exec to lead vaccine and infectious disease R&D Fierce Biotech
The Department of Health - Abu Dhabi and Sanofi Forge Strategic Alliance to Accelerate the Develo...
Sanofi and Regeneron’s Dupixent gets FDA approval for rare skin disease - Investing.com
Sanofi and Regeneron’s Dupixent gets FDA approval for rare skin disease Investing.com
Sanofi exploring vaccine production in Vietnam with local partner - Reuters
Sanofi exploring vaccine production in Vietnam with local partner Reuters
Press release: Sanofi Launches 2025 Global Employee Stock Purchase Plan - GlobeNewswire
Press release: Sanofi Launches 2025 Global Employee Stock Purchase Plan GlobeNewswire
Press Release: Sanofi to acquire Blueprint Medicines, - GlobeNewswire
Press Release: Sanofi to acquire Blueprint Medicines, GlobeNewswire
Sustainable and Equitable Access to Healthcare - Sanofi
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances - BioPharma Dive
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances BioPharma Dive
Sanofi Inks $9.5B Blueprint Buyout to Expand Rare Disease Portfolio - BioSpace
Sanofi Inks $9.5B Blueprint Buyout to Expand Rare Disease Portfolio BioSpace
Sanofi pays $15M for another STAT6 degrader from fruitful Nurix collab - Fierce Biotech
Sanofi pays $15M for another STAT6 degrader from fruitful Nurix collab Fierce Biotech
US FDA approves use of Sanofi's meningococcal vaccine in infants - Reuters
US FDA approves use of Sanofi's meningococcal vaccine in infants Reuters
France's Sanofi to invest at least $20 billion in US through 2030 - Reuters
France's Sanofi to invest at least $20 billion in US through 2030 Reuters
Press Release: Sanofi accelerates global shipping of - GlobeNewswire
Press Release: Sanofi accelerates global shipping of GlobeNewswire
Sanofi to Acquire Blueprint Medicines for Up to $9.5B - Genetic Engineering and Biotechnology News
Sanofi to Acquire Blueprint Medicines for Up to $9.5B Genetic Engineering and Biotechnology News
Sanofi, Regeneron Tout Dupixent’s Effectiveness in Patients With Darker Skin Tone - BioSpace
Sanofi, Regeneron Tout Dupixent’s Effectiveness in Patients With Darker Skin Tone BioSpace
Sanofi opens doors to $130M 'flagship' US office facility in New Jersey - Fierce Pharma
Sanofi opens doors to $130M 'flagship' US office facility in New Jersey Fierce Pharma
Press Release: Sanofi to acquire Vigil Neuroscience, Inc., - GlobeNewswire
Press Release: Sanofi to acquire Vigil Neuroscience, Inc., GlobeNewswire
Sanofi Successfully Prices €1.5 Billion Bond Issue - TipRanks
Sanofi to acquire Vigil Neuroscience in $470 million deal to boost neurological pipeline - Reuters
Sanofi to acquire Vigil Neuroscience in $470 million deal to boost neurological pipeline Reuters
Transforming Regulatory Affairs l Sanofi - Sanofi
French finance minister criticises Sanofi's $20 bln USA investment decision - Reuters
French finance minister criticises Sanofi's $20 bln USA investment decision Reuters
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanofi - SNY - B...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanofi - SNY Bluefield Daily Telegraph
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanofi - SNY - W...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanofi - SNY WV News
COPD Drug Developed by Regeneron, Sanofi Fails Key Test - Investopedia
COPD Drug Developed by Regeneron, Sanofi Fails Key Test Investopedia
Sanofi hops on the US investment bandwagon with $20B commitment through 2030 - Fierce Pharma
Sanofi hops on the US investment bandwagon with $20B commitment through 2030 Fierce Pharma
Sanofi eyes vaccine manufacturing in Vietnam amid tech transfer with local firm - Fierce Pharma
Sanofi eyes vaccine manufacturing in Vietnam amid tech transfer with local firm Fierce Pharma
Sanofi, Regeneron Shares Tumble as Dupixent Follow-Up Fails Phase III COPD Test - BioSpace
Sanofi, Regeneron Shares Tumble as Dupixent Follow-Up Fails Phase III COPD Test BioSpace
Sanofi spices up Type 1 diabetes awareness with sponsorship of new UK girl group - Fierce Pharma
Sanofi spices up Type 1 diabetes awareness with sponsorship of new UK girl group Fierce Pharma
Sanofi gains experimental Alzheimer’s drug through Vigil buyout - BioPharma Dive
Sanofi gains experimental Alzheimer’s drug through Vigil buyout BioPharma Dive
Olympic flame-out: Sanofi scorched for giving Paris 2024 tickets to UK patients - Fierce Pharma
Olympic flame-out: Sanofi scorched for giving Paris 2024 tickets to UK patients Fierce Pharma
Sanofi Just Spent $9.5 Billion on a Rare Disease You've Never Heard Of - Yahoo Finance
Sanofi Just Spent $9.5 Billion on a Rare Disease You've Never Heard Of Yahoo Finance
Sanofi: positive opinion from CHMP for multiple myeloma - MarketScreener
Sanofi: positive opinion from CHMP for multiple myeloma MarketScreener
Sanofi Expands Rare Immunology Portfolio With Blueprint Buyout - Yahoo Finance
Sanofi Expands Rare Immunology Portfolio With Blueprint Buyout Yahoo Finance
Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader...
Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader GlobeNewswire
A New Era of Biopharma Production with AI - Sanofi
Sanofi stays on course amid tariff turmoil - BioPharma Dive
Sanofi stays on course amid tariff turmoil BioPharma Dive
Vigil Neuroscience Enters into Definitive Merger Agreement to be Acquired by Sanofi - GlobeNewswire
Vigil Neuroscience Enters into Definitive Merger Agreement to be Acquired by Sanofi GlobeNewswire
NextGen Scholars: Shaping Future Healthcare Leaders - Sanofi
CEO of pharma giant Sanofi says businesses should stop ‘AI washing’ - Fortune
CEO of pharma giant Sanofi says businesses should stop ‘AI washing’ Fortune
Achieving R&D Excellence to Shape the Medicines of Tomorrow - Sanofi
Achieving R&D Excellence to Shape the Medicines of Tomorrow Sanofi
Inspiring innovation: Sanofi unveils vibrant new flagship office at Morristown’s M Station - Real...
Inspiring innovation: Sanofi unveils vibrant new flagship office at Morristown’s M Station Real Estate NJ
Sanofi’s $130M Morristown flagship puts people first - NJBIZ
Sanofi nets €10B from Opella stake sale, eyes more 'bolt-on' deals - Fierce Pharma
Sanofi nets €10B from Opella stake sale, eyes more 'bolt-on' deals Fierce Pharma
Press Release: Sanofi to acquire Dren Bio’s bispecific - GlobeNewswire
Press Release: Sanofi to acquire Dren Bio’s bispecific GlobeNewswire
Sanofi to buy Blueprint Medicines for over $9 billion - Chemistry World
Sanofi to buy Blueprint Medicines for over $9 billion Chemistry World
Sanofi opens $130M corporate hub in New Jersey as part of $20B U.S. investment push - drugdiscove...
Sanofi opens $130M corporate hub in New Jersey as part of $20B U.S. investment push drugdiscoverytrends.com
The Department of Health - Abu Dhabi and Sanofi Forge Strategic Alliance to Accelerate the Develo...
Sanofi to pour more than $20B into US drug research and manufacturing - BioPharma Dive
Sanofi to pour more than $20B into US drug research and manufacturing BioPharma Dive
Sanofi Appoints James Guy as Country Lead, Canada and General Manager, Specialty Care - Yahoo Fin...
Sanofi Appoints James Guy as Country Lead, Canada and General Manager, Specialty Care Yahoo Finance
Viz.ai Announces Collaboration With Sanofi and Regeneron to Improve Management and Care of Chroni...
Regeneron, Sanofi Stock Falls After Uneven Smoker's Lung Drug Data - Yahoo Finance
Regeneron, Sanofi Stock Falls After Uneven Smoker's Lung Drug Data Yahoo Finance
Meet our A Million Conversations Advisory Group - Sanofi
ASCO 25: Sanofi hopes on-body delivery will boost Sarclisa - Pharmaphorum
ASCO 25: Sanofi hopes on-body delivery will boost Sarclisa Pharmaphorum
Hawaii in $700 million settlement with Bristol-Myers, Sanofi over Plavix warning label - Reuters
Hawaii in $700 million settlement with Bristol-Myers, Sanofi over Plavix warning label Reuters
Sanofi hands back cancer NK cell engager to Innate amid autoimmune pivot - Fierce Biotech
Sanofi hands back cancer NK cell engager to Innate amid autoimmune pivot Fierce Biotech
Sanofi announces new data from two clinical studies on Sarclisa - Yahoo Finance
Sanofi announces new data from two clinical studies on Sarclisa Yahoo Finance
Sanofi Cuts Off Antibody Partner, Forcing 80% Headcount Reduction at IGM - BioSpace
Sanofi Cuts Off Antibody Partner, Forcing 80% Headcount Reduction at IGM BioSpace
Sanofi to buy US blood disorder drugmaker for up to $9.5bn - Financial Times
Sanofi to buy US blood disorder drugmaker for up to $9.5bn Financial Times
Gov. Murphy, Morristown welcome 2,000 Sanofi employees to new office building - Morris County NJ ...
Gov. Murphy, Morristown welcome 2,000 Sanofi employees to new office building Morris County NJ News | Daily Record
FDA Action Alert: Merck, Moderna, Gilead, Regeneron/Sanofi and More - BioSpace
FDA Action Alert: Merck, Moderna, Gilead, Regeneron/Sanofi and More BioSpace
FDA Approves Regeneron Sanofi Treatment For Rare Autoimmune Skin Disorder - Benzinga
FDA Approves Regeneron Sanofi Treatment For Rare Autoimmune Skin Disorder Benzinga
Sanofi and Regeneron's high-flying Dupixent on course for an 'inflection year' in COPD - Fierce P...
Sanofi and Regeneron's high-flying Dupixent on course for an 'inflection year' in COPD Fierce Pharma
Vigil Neuroscience Stock Triples as Drugmaker Agrees to Acquisition by Sanofi - Investopedia
Vigil Neuroscience Stock Triples as Drugmaker Agrees to Acquisition by Sanofi Investopedia
Sanofi licenses immune disease drugs from startup Earendil - BioPharma Dive
Sanofi licenses immune disease drugs from startup Earendil BioPharma Dive
Sanofi to Buy Vigil Neuroscience for About $470 Million - WSJ
Sanofi, Regeneron's IL-33 drug fails one of 2 COPD studies as FDA timeline thrown in doubt - Fier...
Sanofi, Regeneron's IL-33 drug fails one of 2 COPD studies as FDA timeline thrown in doubt Fierce Biotech
Regeneron, Sanofi announce FDA approval of Dupixent for bullous pemphigoid - TipRanks
Regeneron, Sanofi announce FDA approval of Dupixent for bullous pemphigoid TipRanks
Sanofi Hops Aboard US Manufacturing Blitz With $20B Commitment - BioSpace
Sanofi Hops Aboard US Manufacturing Blitz With $20B Commitment BioSpace
Sanofi's quarterly profit boosted by Dupixent and newer drugs; forecast unchanged - Reuters
Sanofi's quarterly profit boosted by Dupixent and newer drugs; forecast unchanged Reuters
US FDA approves Sanofi's bleeding disorder therapy - Reuters
Sanofi's high hopes for $1.1B Kymab anti-inflammatory drug dented after phase 2 asthma failure - ...
Sanofi's high hopes for $1.1B Kymab anti-inflammatory drug dented after phase 2 asthma failure Fierce Biotech
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's rac...
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race Fierce Biotech
Sanofi buys Vigil Neuroscience for $470m in Alzheimer’s push - Pharmaceutical Technology
Sanofi buys Vigil Neuroscience for $470m in Alzheimer’s push Pharmaceutical Technology